Sep 8, 2025
Axxam and B'SYS partner to expand access to validated ion channel cell lines for high-throughput electrophysiology
Axxam S.p.A., a premier provider of integrated early drug discovery services, and B’SYS GmbH, a specialist in ion channel biology, are pleased to announce a strategic collaboration focused on enabling access to validated ion channel cell lines for hit and lead identification through high-throughput electrophysiological screening. B’SYS offers an extensive catalogue of engineered cell lines…
View On WordPress